Corneal cross-linking (CXL) using riboflavin and ultraviolet A (UVA) light has become a
useful treatment option for not only corneal ectasias, such as keratoconus, but also a …

Purpose To evaluate the early-and late-stage complications of accelerated cross-linking (A-
CXL) in a large case series and investigate the relationship of A-CXL complications with …

Purpose To assess clinical results of the 9 mW/5.4 J/cm2 accelerated crosslinking (ACXL) in
the treatment of progressive keratoconus (KC) over a span of 5 years. Methods The …

Purpose To analyse long‐term outcomes of standard cross‐linking (SCXL), accelerated
cross‐linking (ACXL) and transepithelial cross‐linking (TCXL) in the treatment of …

Purpose To evaluate the effectiveness of epithelium-off (epi-off) accelerated corneal
crosslinking (A-CXL, 9 mW/cm2, 10 min) in adult keratoconus (KC) patients. Methods The …

The purpose of this study was to evaluate the effectiveness and safety of a novel buffered
riboflavin solution approved for corneal cross-linking (CXL) in progressive keratoconus and …

Purpose. The aim of our study was to compare the long‐term efficacy and safety of “epi‐off”
conventional and “epi‐off” accelerated corneal cross‐linking (CXL) in patients with …

Purpose To compare the outcomes of accelerated versus standard corneal cross-linking for
the treatment of progressive keratoconus. Methods In this retrospective comparative study …

Purpose This study evaluated the effect of high-fluence accelerated corneal cross-linking on
the resistance to enzymatic digestion, assessing two chromophore/light combinations …

Purpose: To investigate the potential additive effect of systemic supplemental oxygen
administered during accelerated corneal crosslinking (CXL) for progressive keratoconus …